Advertisement

Psychopharmacology

, Volume 174, Issue 4, pp 512–524 | Cite as

Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter

  • Alexander NeumeisterEmail author
  • Theresa Young
  • Juergen Stastny
Review

Abstract

Serotonin systems appear to play a key role in the pathophysiology of major depressive disorder. Consequently, ongoing research determines whether serotonin related genes account for the very robust differential behavioral and neural mechanisms that discriminate patients with depression from healthy controls. Serotonin type 1A receptors and the serotonin transporters are reduced in depression, and recent genetic research in animals and humans has implicated both in depression. Preclinical studies have utilized a variety of animal models that have been used to explain pathophysiological mechanisms in humans, although it is not clear at all whether these models constitute relevant models for depression in humans. However, data from preclinical studies can generate hypotheses that are tested in humans by combining genetic data with behavioral and physiological challenge paradigms and neuroimaging. These studies will enhance our understanding about combined influences from multiple interacting genes, as well as from environmental factors on brain circuits and their function, and about how these mechanisms may contribute to the pathophysiology of neuropsychiatric disorders.

Keywords

Depression 5-HT Pathophysiology Genes Serotonin type 1A receptor Serotonin transporter Pharmacogenetics Pharmacogenomics 

References

  1. Abbott FV, Etienne P, Franklin KB, Morgan MJ, Sewitch MJ, Young SN (1992) Acute tryptophan depletion blocks morphine analgesia in the cold-pressor test in humans. Psychopharmacology 108:60–66PubMedGoogle Scholar
  2. Arias B, Arranz MJ, Gasto C et al. (2002) Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT(1A) receptor gene as putative risk factors in major depression. Mol Psychiatry 7:930–932; Erratum in: Mol Psychiatry 8:246Google Scholar
  3. Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976) “Serotonin depression”—a biochemical subgroup within the affective disorders? Science 191:478–480Google Scholar
  4. Azmitia EC (1999) Serotonin neurons, neuroplasticity, and homeostasis of neural tissue. Neuropsychopharmacology 21:33S–45SCrossRefPubMedGoogle Scholar
  5. Azmitia EC, Whitaker-Azmitia PM (1991) Awakening the sleeping giant: anatomy and plasticity of the brain serotonergic system. J Clin Psychiatry 52 Suppl:4–16Google Scholar
  6. Azmitia EC, Gannon PJ, Kheck NM, Whitaker-Azmitia PM (1996) Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology 14:35–46CrossRefPubMedGoogle Scholar
  7. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152CrossRefPubMedGoogle Scholar
  8. Bellivier F, Laplanche JL, Leboyer M et al. (1997) Serotonin transporter gene and manic depressive illness: an association study. Biol Psychiatry 41:750–752CrossRefPubMedGoogle Scholar
  9. Bellivier F, Szoke A, Henry C et al. (2000) Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 48:319–322CrossRefPubMedGoogle Scholar
  10. Benkelfat C, Ellenbogen MA, Dean P, Palmour RM, Young SN (1994) Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry 51:687–697PubMedGoogle Scholar
  11. Bhagwagar Z, Montgomery AJ, Grasby PM, Cowen PJ (2003) Lack of effect of a single dose of hydrocortisone on serotonin(1A) receptors in recovered depressed patients measured by positron emission tomography with [11C]WAY-100635. Biol Psychiatry 54:890–895CrossRefPubMedGoogle Scholar
  12. Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004) Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9:386–392CrossRefPubMedGoogle Scholar
  13. Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H (2000) Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry 5:193–195CrossRefPubMedGoogle Scholar
  14. Bortolozzi A, Amargos-Bosch M, Toth M, Artigas F, Adell A (2004) In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice. J Neurochem 88:1373–1379PubMedGoogle Scholar
  15. Carli M, Afkhami-Dastjerdian S, Reader TA (1996) [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline. J Psychiatr Neurosci 21:114–122Google Scholar
  16. Carpenter LL, Anderson GM, Pelton GH et al. (1998) Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology 19:26–35CrossRefPubMedGoogle Scholar
  17. Carpenter LL, Tyrka AR, McDougle CJ et al. (2004) Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology 29:777–784CrossRefPubMedGoogle Scholar
  18. Caspi A, Sugden K, Moffitt TE et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386–389CrossRefPubMedGoogle Scholar
  19. Cloninger CR, Przybeck TR, Svrakic DM (1991) The tridimensional personality questionnaire: U.S. normative data. Psychol Rep 69:1047–1057PubMedGoogle Scholar
  20. Collier DA, Stober G, Li T et al. (1996) A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453–460PubMedGoogle Scholar
  21. Cook EH Jr, Courchesne R, Lord C et al. (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247–250CrossRefPubMedGoogle Scholar
  22. Coppen A, Eccleston EG, Peet M (1973) Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2:60–63CrossRefPubMedGoogle Scholar
  23. Courtet P, Buresi C, Abbar M et al. (2003) No association between non-violent suicidal behavior and the serotonin transporter promotor polymorphism. Am J Med Genet 1:72–76CrossRefGoogle Scholar
  24. Courtet P, Picot MC, Bellivier F et al. (2004) Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biol Psychiatry 55:46–51CrossRefPubMedGoogle Scholar
  25. Cowen PJ, Charig EM (1987) Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry 44:958–966PubMedGoogle Scholar
  26. Cowen PJ, Parry-Billings M, Newsholme EA (1989) Decreased plasma tryptophan levels in major depression. J Affect Disord 16:27–31CrossRefPubMedGoogle Scholar
  27. Czyrak A, Czepiel K, Mackowiak M, Chocyk A, Wedzony K (2003) Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex. Brain Res 989:42–51CrossRefPubMedGoogle Scholar
  28. Drevets WC, Frank E, Price JC et al. (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46:1375–1387CrossRefPubMedGoogle Scholar
  29. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH (1997) No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Mol Psychiatry 2:224–226CrossRefPubMedGoogle Scholar
  30. Egede LE (2004) Diabetes, major depression, and functional disability among U.S. adults. Diabetes Care 27:421–428PubMedGoogle Scholar
  31. Erdmann J, Shimron-Abarbanell D, Cichon S et al. (1995) Systematic screening for mutations in the promoter and the coding region of the 5-HT1A gene. Am J Med Genet 60:393–399PubMedGoogle Scholar
  32. Evans DL, Charney DS (2003) Mood disorders and medical illness: a major public health problem. Biol Psychiatry 54:177–180CrossRefPubMedGoogle Scholar
  33. Flory JD, Manuck SB, Ferrell RE, Dent KM, Peters DG, Muldoon MF (1999) Neuroticism is not associated with the serotonin transporter (5-HTTLPR) polymorphism. Mol Psychiatry 4:93–96CrossRefPubMedGoogle Scholar
  34. Frazer A, Hensler JG (1990) 5-HT1A receptors and 5-HT1A-mediated responses: effect on treatments that modify serotonergic neurotransmission. In: Whitaker-Azmitia PM, Peroutka SJ (eds) The neuropharmacology of serotonin. The New York Academy of Sciences, New York, pp 460–475Google Scholar
  35. Gaspar P, Cases O, Maroteaux L (2003) The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002–1012CrossRefPubMedGoogle Scholar
  36. Ginovart N, Wilson AA, Meyer JH, Hussey D, Houle S (2003) [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse 47:123–133CrossRefPubMedGoogle Scholar
  37. Gold PW, Gabry KE, Yasuda MR, Chrousos GP (2002) Divergent endocrine abnormalities in melancholic and atypical depression: clinical and pathophysiologic implications. Endocrinol Metab Clin N Am 31:37–62, viGoogle Scholar
  38. Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83–87CrossRefPubMedGoogle Scholar
  39. Greenberg BD, Li Q, Lucas FR et al. (2000) Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample. Am J Med Genet 96:202–216CrossRefPubMedGoogle Scholar
  40. Groenink L, Pattij T, De Jongh R et al. (2003a) 5-HT1A receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur J Pharmacol 463:185–197CrossRefPubMedGoogle Scholar
  41. Groenink L, van Bogaert MJ, van der Gugten J, Oosting RS, Olivier B (2003b) 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behav Pharmacol 14:369–383PubMedGoogle Scholar
  42. Gross C, Zhuang X, Start K et al. (2002) Serotonin1A receptor acts during development to establish normal anxiety-like behavior in the adult. Nature 416:396–400CrossRefPubMedGoogle Scholar
  43. Guttmacher AE, Collins FS (2002) Genomic medicine—a primer. N Engl J Med 347:1512–1520CrossRefPubMedGoogle Scholar
  44. Hariri AR, Mattay VS, Tessitore A et al. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297:400–403CrossRefPubMedGoogle Scholar
  45. He M, Sibille E, Benjamin D, Toth M, Shippenberg T (2001) Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res 902:11–17CrossRefPubMedGoogle Scholar
  46. Healy D, Leonard BE (1987) Monoamine transport in depression: kinetics and dynamics. J Affect Disord 12:91–103CrossRefPubMedGoogle Scholar
  47. Heils A, Teufel A, Petri S et al. (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624PubMedGoogle Scholar
  48. Heils A, Mossner R, Lesch KP (1997) The human serotonin transporter gene polymorphism—basic research and clinical implications. J Neural Transm 104:1005–1014PubMedGoogle Scholar
  49. Heim C, Nemeroff CB (2001) The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol Psychiatry 49:1023–1039CrossRefPubMedGoogle Scholar
  50. Heinz A, Jones DW, Mazzanti C et al. (2000) A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity. Biol Psychiatry 47:643–649CrossRefPubMedGoogle Scholar
  51. Heisler LK, Chu HM, Brennan TJ et al. (1998) Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc Natl Acad Sci USA 95:15049–15054CrossRefPubMedGoogle Scholar
  52. Hendricks T, Francis N, Fyodorov D, Deneris ES (1999) The ETS domain factor Pet-1 is an early and precise marker of central serotonin neurons and interacts with a conserved element in serotonergic genes. J Neurosci 19:10348–10356PubMedGoogle Scholar
  53. Hensler JG, Kovachich GB, Frazer A (1991) A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131–144PubMedGoogle Scholar
  54. Jorm AF, Henderson AS, Jacomb PA et al. (1998) An association study of a functional polymorphism of the serotonin transporter gene with personality and psychiatric symptoms. Mol Psychiatry 3:449–451CrossRefPubMedGoogle Scholar
  55. Kawanishi Y, Harada S, Tachikawa H et al. (1998) Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. Am J Med Genet 81:434–439CrossRefPubMedGoogle Scholar
  56. Kim DK, Lim SW, Lee S et al. (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11:215–219PubMedGoogle Scholar
  57. Klaassen T, Riedel WJ, van Someren A, Deutz NE, Honig A, van Praag HM (1999) Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders. Biol Psychiatry 46:489–497CrossRefPubMedGoogle Scholar
  58. Knobelman DA, Hen R, Blendy JA, Lucki I (2001a) Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. J Pharmacol Exp Ther 298:1092–1100PubMedGoogle Scholar
  59. Knobelman DA, Hen R, Lucki I (2001b) Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J Pharmacol Exp Ther 298:1083–1091PubMedGoogle Scholar
  60. Knott VJ, Howson AL, Perugini M, Ravindran AV, Young SN (1999) The effect of acute tryptophan depletion and fenfluramine on quantitative EEG and mood in healthy male subjects. Biol Psychiatry 46:229–238CrossRefPubMedGoogle Scholar
  61. Lemonde S, Turecki G, Bakish D et al. (2003) Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23:8788–8799PubMedGoogle Scholar
  62. Lesch KP, Balling U, Gross J et al. (1994) Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 95:157–162PubMedGoogle Scholar
  63. Lesch KP, Bengel D, Heils A et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527–1531CrossRefPubMedGoogle Scholar
  64. Li T, Holmes C, Sham PC et al. (1997) Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer’s disease. Neuroreport 8:683–686PubMedGoogle Scholar
  65. Little KY, McLaughlin DP, Zhang L et al. (1998) Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. Am J Psychiatry 155:207–213PubMedGoogle Scholar
  66. Mah EJ, Cunningham KA (1993) Electrophysiological studies of serotnergic (5-HT) modulation of glutamate-evoked activity in amygdala neurons. Soc Neurosci Abstr 19:1554Google Scholar
  67. Malberg JE, Duman RS (2003) Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology 28:1562–1571CrossRefPubMedGoogle Scholar
  68. Malhotra AK, Goldman D, Mazzanti C, Clifton A, Breier A, Pickar D (1998) A functional serotonin transporter (5-HTT) polymorphism is associated with psychosis in neuroleptic-free schizophrenics. Mol Psychiatry 3:328–332CrossRefPubMedGoogle Scholar
  69. Malison RT, Price LH, Berman R et al. (1998) Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry 44:1090–1098CrossRefPubMedGoogle Scholar
  70. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541–547CrossRefPubMedGoogle Scholar
  71. Manji HK, Quiroz JA, Sporn J et al. (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol Psychiatry 53:707–742CrossRefPubMedGoogle Scholar
  72. Mann JJ, McBride PA, Malone KM, DeMeo M, Keilp J (1995) Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 13:53–64PubMedGoogle Scholar
  73. Mann JJ, Huang YY, Underwood MD et al. (2000) A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch Gen Psychiatry 57:729–738CrossRefPubMedGoogle Scholar
  74. Mazzanti CM, Lappalainen J, Long JC et al. (1998) Role of the serotonin transporter promoter polymorphism in anxiety- related traits. Arch Gen Psychiatry 55:936–940CrossRefPubMedGoogle Scholar
  75. McDougle CJ, Epperson CN, Price LH, Gelernter J (1998) Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder. Mol Psychiatry 3:270–273CrossRefPubMedGoogle Scholar
  76. Meijer OC, de Kloet ER (1994) Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol 266:255–261CrossRefPubMedGoogle Scholar
  77. Meijer OC, de Kloet ER (1995) A role for the mineralocorticoid receptor in a rapid and transient suppression of hippocampal 5-HT1A receptor mRNA by corticosterone. J Neuroendocrinol 7:653–657PubMedGoogle Scholar
  78. Meijer OC, Van Oosten RV, De Kloet ER (1997) Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience 80:419–426CrossRefPubMedGoogle Scholar
  79. Meltzer HY, Maes M (1995) Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38:450–457CrossRefPubMedGoogle Scholar
  80. Mendelson SD, McEwen BS (1991) Autoradiographic analyses of the effects of restraint-induced stress on 5-HT1A, 5-HT1C and 5-HT2 receptors in the dorsal hippocampus of male and female rats. Neuroendocrinology 54:454–461PubMedGoogle Scholar
  81. Mendelson SD, McEwen BS (1992) Autoradiographic analyses of the effects of adrenalectomy and corticosterone on 5-HT1A and 5-HT1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology 55:444–450PubMedGoogle Scholar
  82. Meyer JH, Wilson AA, Ginovart N et al. (2001) Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am J Psychiatry 158:1843–1849CrossRefPubMedGoogle Scholar
  83. Meyer JH, Wilson AA, Sagrati S et al. (2004) Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. Am J Psychiatry 161:826–835CrossRefPubMedGoogle Scholar
  84. Minov C, Baghai TC, Schule C et al. (2001) Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303:119–122CrossRefPubMedGoogle Scholar
  85. Montgomery AJ, Bench CJ, Young AH et al. (2001) PET measurement of the influence of corticosteroids on serotonin-1A receptor number. Biol Psychiatry 50:668–676CrossRefPubMedGoogle Scholar
  86. Moreno FA, Gelenberg AJ, Heninger GR et al. (1999) Tryptophan depletion and depressive vulnerability. Biol Psychiatry 46:498–505CrossRefPubMedGoogle Scholar
  87. Murphy FC, Smith KA, Cowen PJ, Robbins TW, Sahakian BJ (2002) The effects of tryptophan depletion on cognitive and affective processing in healthy volunteers. Psychopharmacology 163:42–53CrossRefPubMedGoogle Scholar
  88. Murphy DL, Uhl GR, Holmes A et al. (2003) Experimental gene interaction studies with SERT mutant mice as models for human polygenic and epistatic traits and disorders. Genes Brain Behav 2:350–364CrossRefPubMedGoogle Scholar
  89. Nakhai B, Nielsen DA, Linnoila M et al. (1995) Two naturally occurring amino acid substitutions in the human 5-HT1A receptor: glycine 22 to serine 22 and isoleucine 28 to valine 28. Biochem Biophys Res Commun 210:530–536CrossRefPubMedGoogle Scholar
  90. Neumeister A (2003) Tryptophan depletion, serotonin, and depression: where do we stand? Psychopharmacol Bull 37:99–115Google Scholar
  91. Neumeister A, Konstantinidis A, Stastny J et al. (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59:613–620CrossRefPubMedGoogle Scholar
  92. Neumeister A, Bain E, Nugent AC et al. (2004a) Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 24:589–591CrossRefPubMedGoogle Scholar
  93. Neumeister A, Nugent AC, Waldeck T et al. (2004b) Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Arch Gen Psychiatry (in press)Google Scholar
  94. Oldman A, Walsh A, Salkovskis P, Fairburn CG, Cowen PJ (1995) Biochemical and behavioural effects of acute tryptophan depletion in abstinent bulimic subjects: a pilot study. Psychol Med 25:995–1001PubMedGoogle Scholar
  95. Oliveira JR, Gallindo RM, Maia LG et al. (1998) The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer’s disease. Mol Psychiatry 3:438–441CrossRefPubMedGoogle Scholar
  96. Ou XM, Jafar-Nejad H, Storring JM, Meng JH, Lemonde S, Albert PR (2000) Novel dual repressor elements for neuronal cell-specific transcription of the rat 5-HT1A receptor gene. J Biol Chem 275:8161–8168CrossRefPubMedGoogle Scholar
  97. Ou XM, Lemonde S, Jafar-Nejad H et al. (2003) Freud-1: a neuronal calcium-regulated repressor of the 5-HT1A receptor gene. J Neurosci 23:7415–7425PubMedGoogle Scholar
  98. Overstreet DH, Commissaris RC, De La Garza R II, File SE, Knapp DJ, Seiden LS (2003) Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6:101–110CrossRefPubMedGoogle Scholar
  99. Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40:288–295PubMedGoogle Scholar
  100. Palacios J, Pazos A, Hoyer D (1987) Characterisation and mapping of 5-HT1A receptors in animals and in man. In: Dourish C, Ahlenius S, Hutson P (eds) Brain 5-HT1A receptors—behavioural and neurochemical pharmacology, vol 67. Ellis Horwood, Chichester, chapter 6Google Scholar
  101. Parks CL, Shenk T (1996) The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1. J Biol Chem 271:4417–4430CrossRefPubMedGoogle Scholar
  102. Parsons LH, Kerr TM, Tecott LH (2001) 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J Neurochem 77:607–617CrossRefPubMedGoogle Scholar
  103. Pattij T, Hijzen TH, Groenink L et al. (2001) Stress-induced hyperhermia in the 5-HT(1A) receptor knockout mouse is normal. Biol Psychiatry 49:569–674CrossRefPubMedGoogle Scholar
  104. Pattij T, Groenink L, Hijzen TH et al. (2002a) Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology 27:380–390CrossRefPubMedGoogle Scholar
  105. Pattij T, Groenink L, Oosting RS et al. (2002b) GABA(A)-benzodiazepine receptor complex sensitivity in 5-HT(1A) receptor knockout mice on a 129/Sv background. Eur J Pharmacol 447:67–74CrossRefPubMedGoogle Scholar
  106. Pazos A, Probst A, Palacios JM (1987) Serotonin receptors in the human brain. III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience 21:97–122CrossRefPubMedGoogle Scholar
  107. Pollock BG, Ferrell RE, Mulsant BH et al. (2000) Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23:587–590CrossRefPubMedGoogle Scholar
  108. Pranzatelli MR (1994) Dissociation of the plasticity of 5-HT1A sites and 5-HT transporter sites. Neurochem Res 19:311–315PubMedGoogle Scholar
  109. Quintin P, Benkelfat C, Launay JM et al. (2001) Clinical and neurochemical effect of acute tryptophan depletion in unaffected relatives of patients with bipolar affective disorder. Biol Psychiatry 50:184–190CrossRefPubMedGoogle Scholar
  110. Ramamoorthy S, Bauman AL, Moore KR et al. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 90:2542–2546PubMedGoogle Scholar
  111. Ramboz S, Oosting R, Amara DA et al. (1998) Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc Natl Acad Sci 95:14476–14481CrossRefPubMedGoogle Scholar
  112. Rees M, Norton N, Jones I et al. (1997) Association studies of bipolar disorder at the human serotonin transporter gene (hSERT; 5HTT). Mol Psychiatry 2:398–402CrossRefPubMedGoogle Scholar
  113. Regina MJ, Winter JC, Rabin RA (2003) Characterization of a novel effect of serotonin 5-HT1A and 5-HT2A receptors: increasing cGMP levels in rat frontal cortex. Neuropharmacology 45:1041–1049CrossRefPubMedGoogle Scholar
  114. Roses AD (2000) Idiosyncratic reactions to drugs: can medicine response profiles provide a dynamic drug surveillance system? Clin Chem Lab Med 38:815–818PubMedGoogle Scholar
  115. Roses AD (2002) Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 1:541–549CrossRefPubMedGoogle Scholar
  116. Rotondo A, Mazzanti C, Dell’Osso L et al. (2002) Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159:23–29CrossRefPubMedGoogle Scholar
  117. Rudisch B, Nemeroff CB (2003) Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry 54:227–240CrossRefPubMedGoogle Scholar
  118. Sander T, Harms H, Lesch KP et al. (1997) Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcohol Clin Exp Res 21:1356–1359PubMedGoogle Scholar
  119. Sargent PA, Kjaer KH, Bench CJ et al. (2000) Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57:174–180CrossRefPubMedGoogle Scholar
  120. Shioe K, Ichimiya T, Suhara T et al. (2003) No association between genotype of the promoter region of serotonin transporter gene and serotonin transporter binding in human brain measured by PET. Synapse 48:184–188CrossRefPubMedGoogle Scholar
  121. Sibille E, Pavlides C, Benke D, Toth M (2000) Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J Neurosci 20:2758–2765PubMedGoogle Scholar
  122. Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci 34:1029–1039CrossRefPubMedGoogle Scholar
  123. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3:508–511CrossRefPubMedGoogle Scholar
  124. Smith KA, Fairburn CG, Cowen PJ (1997) Relapse of depression after rapid depletion of tryptophan. Lancet 349:915–919CrossRefPubMedGoogle Scholar
  125. Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27:707–715CrossRefPubMedGoogle Scholar
  126. Spurlock G, Buckland P, O’Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5HT transporter. Neuropharmacology 33:433–440CrossRefPubMedGoogle Scholar
  127. Storring JM, Charest A, Cheng P, Albert PR (1999) TATA-driven transcriptional initiation and regulation of the rat serotonin 5-HT1A receptor gene. J Neurochem 72:2238–2247CrossRefPubMedGoogle Scholar
  128. Suhara T, Takano A, Sudo Y et al. (2003) High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography. Arch Gen Psychiatry 60:386–391CrossRefPubMedGoogle Scholar
  129. Toth M (2003) 5-HT1A receptor knockout mouse as a genetic model of anxiety. Eur J Pharmacol 463:177–184CrossRefPubMedGoogle Scholar
  130. Verge D, Daval G, Marcinkiewicz M et al. (1986) Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci 6:3474–3482PubMedGoogle Scholar
  131. Voderholzer U, Hornyak M, Thiel B et al. (1998) Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18:112–124CrossRefPubMedGoogle Scholar
  132. Weller A, Leguisamo AC, Towns L et al. (2003) Maternal effects in infant and adult phenotypes of 5HT1A and 5HT1B receptor knockout mice. Dev Psychobiol 42:194–205CrossRefPubMedGoogle Scholar
  133. Welner SA, De Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE (1989) Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347–352PubMedGoogle Scholar
  134. Whitaker-Azmitia PM, Azmitia EC (1989) Stimulation of astroglial serotonin receptors produces culture media which regulates growth of serotonergic neurons. Brain Res 497:80–85CrossRefPubMedGoogle Scholar
  135. Whitaker-Azmitia PM, Murphy R, Azmitia EC (1990) Stimulation of astroglial 5-HT1Areceptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology. Brain Res 528:155–158CrossRefPubMedGoogle Scholar
  136. Whitaker-Azmitia PM, Clarke C, Azmitia EC (1993) Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action. Synapse 14:201–205PubMedGoogle Scholar
  137. Willeit M, Stastny J, Pirker W et al. (2001) No evidence for in vivo regulation of midbrain serotonin transporter availability by serotonin transporter promoter gene polymorphism. Biol Psychiatry 50:8–12CrossRefPubMedGoogle Scholar
  138. World Health Organization (2001) Mental health: new understanding, new hope. World Health Organization, GenevaGoogle Scholar
  139. Wu S, Comings DE (1999) A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 9:105–106PubMedGoogle Scholar
  140. Yatham LN, Liddle PF, Shiah IS et al. (2001) Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET study. Br J Psychiatry 178:448–453CrossRefPubMedGoogle Scholar
  141. Yu YW, Tsai SJ, Chen TJ, Lin CH, Hong CJ (2002) Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol Psychiatry 7:1115–1119CrossRefPubMedGoogle Scholar
  142. Zanardi R, Benedetti F, Di Bella D, Catalano M, Smeraldi E (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J Clin Psychopharmacol 20:105–107CrossRefPubMedGoogle Scholar
  143. Zhuang X, Gross C, Santarelli L, Compan V, Trillat AC, Hen R (1999) Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors. Neuropsychopharmacology 21:S52–S60CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Alexander Neumeister
    • 1
    Email author
  • Theresa Young
    • 2
  • Juergen Stastny
    • 3
  1. 1.Clinical Neuroscience Division, Department of Psychiatry, VA National Center for PTSD (116-A)Yale University School of MedicineWest HavenUSA
  2. 2.Mood and Anxiety Disorders ProgramNIMHBethesdaUSA
  3. 3.Department of General PsychiatryUniversity of ViennaViennaAustria

Personalised recommendations